NVS Operating Cash Flow (Statement)

Novartis AG Common Stock · Operating Cash Flow (Statement)

NVS logo

NVS Operating Cash Flow (Statement)

Latest reported$18.39B
NVS TTM Cash from Operations ($6.65B → $18.39B)
High-resolution chart · PNG

NVS operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
18,388,756,644
19,164,702,452
19,133,702,452
21,073,000,000
20,788,000,000
18,999,000,000
17,619,000,000
15,973,000,000
15,065,000,000
13,766,000,000
14,458,000,000
16,022,000,000
15,365,000,000
15,544,000,000
14,236,000,000
14,009,000,000
14,213,000,000
14,590,000,000
15,071,000,000
15,192,000,000
13,423,000,000
13,252,000,000
13,650,000,000
13,185,000,000
14,591,000,000
13,741,000,000
13,625,000,000
13,851,000,000
13,339,000,000
14,170,000,000
14,272,000,000
13,914,000,000
13,450,000,000
13,090,000,000
12,621,000,000
12,804,000,000
12,449,000,000
11,978,000,000
11,475,000,000
12,041,000,000
11,936,000,000
11,735,000,000
11,897,000,000
12,945,000,000
13,830,000,000
14,261,000,000
13,898,000,000
13,143,000,000
13,511,000,000
12,687,000,000
13,174,000,000
13,351,000,000
13,038,000,000
13,506,000,000
14,194,000,000
14,289,000,000
14,457,000,000
14,918,000,000
14,309,000,000
14,164,000,000
13,157,000,000
12,667,000,000
14,067,000,000
13,956,000,000
13,883,000,000
13,545,000,000
12,191,000,000
11,008,000,000
10,730,000,000
9,982,000,000
9,769,000,000
1,469,000,000
8,783,000,000
8,726,000,000
9,210,000,000
16,517,000,000
8,844,000,000
8,790,000,000
8,710,000,000
8,680,000,000
8,701,000,000
8,267,000,000
8,080,000,000
7,581,000,000
7,179,000,000
7,520,000,000
6,725,000,000
6,849,000,000
6,591,000,000
6,055,000,000
6,652,000,000
7,193,000,000
6,626,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.